Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of DPP IV Inhibitors (DPP-4 Inhibitors) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of DPP IV Inhibitors (DPP-4 Inhibitors)market, defines the market attractiveness level of DPP IV Inhibitors (DPP-4 Inhibitors) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of DPP IV Inhibitors (DPP-4 Inhibitors) industry, describes the types of DPP IV Inhibitors (DPP-4 Inhibitors) market, the applications of major players and the market size, and deeply analyzes the current situation of the global DPP IV Inhibitors (DPP-4 Inhibitors) market and the development prospects and opportunities of DPP IV Inhibitors (DPP-4 Inhibitors) industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global DPP IV Inhibitors (DPP-4 Inhibitors) market in Chapter 13.
By Player:
Merck
AstraZeneca
Mitsubishi Tanabe Pharma
Takeda
Boehringer
Novartis
Eli Lilly
By Type:
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others
By End-User:
Hospital
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 DPP IV Inhibitors (DPP-4 Inhibitors) Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 DPP IV Inhibitors (DPP-4 Inhibitors) Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 DPP IV Inhibitors (DPP-4 Inhibitors) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 DPP IV Inhibitors (DPP-4 Inhibitors) Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis and Outlook to 2022
-
7.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Consumption (2017-2022)
-
7.2 United States DPP IV Inhibitors (DPP-4 Inhibitors) Consumption (2017-2022)
-
7.3 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Consumption (2017-2022)
-
7.4 China DPP IV Inhibitors (DPP-4 Inhibitors) Consumption (2017-2022)
-
7.5 Japan DPP IV Inhibitors (DPP-4 Inhibitors) Consumption (2017-2022)
-
7.6 India DPP IV Inhibitors (DPP-4 Inhibitors) Consumption (2017-2022)
-
7.7 South Korea DPP IV Inhibitors (DPP-4 Inhibitors) Consumption (2017-2022)
8 Region and Country-wise DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis and Outlook to 2028
-
8.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast (2022-2028)
-
8.2 United States DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast (2022-2028)
-
8.3 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast (2022-2028)
-
8.4 China DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast (2022-2028)
-
8.5 Japan DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast (2022-2028)
-
8.6 India DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast (2022-2028)
-
8.7 South Korea DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast (2022-2028)
9 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Outlook by Types and Applications to 2022
-
9.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sitagliptin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vildagliptin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Saxagliptin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Linagliptin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Outlook by Types and Applications to 2028
-
10.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Sitagliptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Vildagliptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Saxagliptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Linagliptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global DPP IV Inhibitors (DPP-4 Inhibitors) Import and Export Analysis (Top 5 Countries)
-
11.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 DPP IV Inhibitors (DPP-4 Inhibitors) Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
14.3 Mitsubishi Tanabe Pharma
-
14.3.1 Mitsubishi Tanabe Pharma Company Details
-
14.3.2 Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
14.4 Takeda
-
14.4.1 Takeda Company Details
-
14.4.2 Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
14.5 Boehringer
-
14.5.1 Boehringer Company Details
-
14.5.2 Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Details
-
14.7.2 Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of DPP IV Inhibitors (DPP-4 Inhibitors)
-
Figure DPP IV Inhibitors (DPP-4 Inhibitors) Picture
-
Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Consumption by Country (2017-2022)
-
Figure United States DPP IV Inhibitors (DPP-4 Inhibitors) Consumption and Growth Rate (2017-2022)
-
Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Consumption and Growth Rate (2017-2022)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Consumption and Growth Rate (2017-2022)
-
Figure Japan DPP IV Inhibitors (DPP-4 Inhibitors) Consumption and Growth Rate (2017-2022)
-
Figure India DPP IV Inhibitors (DPP-4 Inhibitors) Consumption and Growth Rate (2017-2022)
-
Figure South Korea DPP IV Inhibitors (DPP-4 Inhibitors) Consumption and Growth Rate (2017-2022)
-
Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast by Country (2022-2028)
-
Figure United States DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast and Growth Rate (2022-2028)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea DPP IV Inhibitors (DPP-4 Inhibitors) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sitagliptin Consumption and Growth Rate (2017-2022)
-
Figure Global Vildagliptin Consumption and Growth Rate (2017-2022)
-
Figure Global Saxagliptin Consumption and Growth Rate (2017-2022)
-
Figure Global Linagliptin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Sitagliptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vildagliptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Saxagliptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Linagliptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Import by Region (Top 5 Countries) (2017-2028)
-
Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
Table Boehringer (Foundation Year, Company Profile and etc.)
-
Table Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Product and Service
-
